JPRN-UMIN000016173已完成2 期
A phase 2 trial of weekly nab-paclitaxel for advanced non-small cell lung cancer without EGFR mutation nor ALK fusion gene in salvage setting - NICE Salvage study
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 38
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1)symptomatic brain metastasis 2)massive or uncontrolable pleural effusion 3)less than two weeks after palliative irradiation for bone metastases or the brain metastasis except the primary tumor 4)previous chemotherapy with paclitaxel or nab-paclitaxel 5)active concomitant malignancy 6)active infectious disease 7)severe comorbidity 8)history of severe drug allergy 9)continuous steroid therapy 10)phsychiatry disease 11)pregnant or lactating woman 12)HBs antigen positive 13)Peripheral neuropathy>CTCAE Grade2 14)interstitial pneumoia or active lung fibrosis on chest X-ray 15)Otherwise determined by the investigator to be unsuitable as a subject in this study
研究者
相似试验
已完成
不适用
Phase 2 trial of weekly Nab paclitaxel for advanced gastric cancer patients with prior chemotherapyadvanced advanced for gastric cancer patients with prior chemotherapyJPRN-UMIN000013105Toho University Graduate School of Medicine25
已完成
2 期
Phase 2 trial of weekly Nab paclitaxel for advanced gastric cancer patients with prior chemotherapyAdvanced Gastric CancerJPRN-UMIN000011882Teikyo University School of Medicine21
招募中
不适用
Phase II trial of weekly Nab-Paclitaxel as second-line chemotherapy for unrecectable or recurrent advanced gastric cancer.Advanced Gastric CancerJPRN-UMIN000015968Tottori University35
招募中
2 期
Phese 2 trial of weekly nab-paclitaxel in combination with gemcitabine in patients with metastatic breast cancer who have failed prior chemotherapyMetastatic and Recurrenced Breast CancerJPRN-UMIN000009153Toho University Omori Medical Center20
招募中
2 期
Phese 2 trial of weekly nab-paclitaxel in combination with gemcitabine in partients with metastatic breast cancerJPRN-UMIN000006427Toho University Omori Medical Center40
